Arch Biopartners Inc
XTSX:ARCH

Watchlist Manager
Arch Biopartners Inc Logo
Arch Biopartners Inc
XTSX:ARCH
Watchlist
Price: 2 CAD -2.44%
Market Cap: 129.3m CAD
Have any thoughts about
Arch Biopartners Inc?
Write Note

Arch Biopartners Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arch Biopartners Inc
Operating Expenses Peer Comparison

Comparables:
ABCL
RP
IOT

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Arch Biopartners Inc
XTSX:ARCH
Operating Expenses
-CA$10m
CAGR 3-Years
-1%
CAGR 5-Years
-39%
CAGR 10-Years
-39%
Abcellera Biologics Inc
NASDAQ:ABCL
Operating Expenses
-$275.2m
CAGR 3-Years
-53%
CAGR 5-Years
-96%
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Operating Expenses
-CA$1.7m
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
7%
Innovotech Inc
XTSX:IOT
Operating Expenses
-CA$1.4m
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-2%

See Also

What is Arch Biopartners Inc's Operating Expenses?
Operating Expenses
-10m CAD

Based on the financial report for Jun 30, 2024, Arch Biopartners Inc's Operating Expenses amounts to -10m CAD.

What is Arch Biopartners Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-39%

Over the last year, the Operating Expenses growth was -16%. The average annual Operating Expenses growth rates for Arch Biopartners Inc have been -1% over the past three years , -39% over the past five years , and -39% over the past ten years .

Back to Top